Evolution of risk stratification and sudden death prevention in hypertrophic cardiomyopathy: Twenty years with the implantable cardioverter-defibrillator-Reference-Cited by-同舟云学术

Evolution of risk stratification and sudden death prevention in hypertrophic cardiomyopathy: Twenty years with the implantable cardioverter-defibrillator

Published:2021-06 Issue:6 Volume:18 Page:1012-1023
ISSN:1547-5271
Container-title:Heart Rhythm
language:en
Short-container-title:Heart Rhythm

Author:

Maron Barry J.,Rowin Ethan J.,Maron Martin S.

Publisher

Elsevier BV

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Reference107 articles.

1. Clinical course and management of hypertrophic cardiomyopathy;Maron;N Engl J Med,2018

2. Global burden of hypertrophic cardiomyopathy;Maron;JACC Heart Fail,2018

3. New perspectives on the prevalence of hypertrophic cardiomyopathy;Semsarian;J Am Coll Cardiol,2015

4. 2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy;Elliott;Eur Heart J,2014

5. 2011 ACCF/AHA guidelines for the diagnosis and treatment of hypertrophic cardiomyopathy;Gersh;Circulation,2011

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chasing the molecular background of hypertrophic cardiomyopathy: The continuing saga to predict adverse outcomes with sarcomere mutations;International Journal of Cardiology;2024-11

2. Tricuspid valve surgery following septal myectomy in patients with a cardiac implantable electronic device;JTCVS Open;2024-08

3. The Difficulty in Navigating a Storm Without a Compass;JACC: Case Reports;2024-08

4. How Investigative Reporting and the ‘Fourth Estate’ Saved Hypertrophic Cardiomyopathy…Twice;The American Journal of Medicine;2024-07

5. Significance and Frequency of Incidental Fortuitous Clinical Identifications of Hypertrophic Cardiomyopathy;JACC: Advances;2024-06